A carbamazepine trial in chronic, treatment-refractory schizophrenia

J. Sramek; J. Herrera; J. Costa; C. Heh; T. Tran-Johnson; G. Simpson

doi:10.1176/ajp.145.6.748

A carbamazepine trial in chronic, treatment-refractory schizophrenia

J. Sramek, J. Herrera, J. Costa, C. Heh, T. Tran-Johnson, G. Simpson

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.

Original language	English (US)
Pages (from-to)	748-750
Number of pages	3
Journal	American Journal of Psychiatry
Volume	145
Issue number	6
DOIs	https://doi.org/10.1176/ajp.145.6.748
State	Published - 1988
Externally published	Yes

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

10.1176/ajp.145.6.748

Cite this

@article{c50f779fc6c14ebbb8e9a7a459001760,

title = "A carbamazepine trial in chronic, treatment-refractory schizophrenia",

abstract = "Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.",

author = "J. Sramek and J. Herrera and J. Costa and C. Heh and T. Tran-Johnson and G. Simpson",

year = "1988",

doi = "10.1176/ajp.145.6.748",

language = "English (US)",

volume = "145",

pages = "748--750",

journal = "American Journal of Psychiatry",

issn = "0002-953X",

publisher = "American Psychiatric Association",

number = "6",

}

TY - JOUR

T1 - A carbamazepine trial in chronic, treatment-refractory schizophrenia

AU - Sramek, J.

AU - Herrera, J.

AU - Costa, J.

AU - Heh, C.

AU - Tran-Johnson, T.

AU - Simpson, G.

PY - 1988

Y1 - 1988

N2 - Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.

AB - Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.

UR - http://www.scopus.com/inward/record.url?scp=0023898909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023898909&partnerID=8YFLogxK

U2 - 10.1176/ajp.145.6.748

DO - 10.1176/ajp.145.6.748

M3 - Article

C2 - 3285702

AN - SCOPUS:0023898909

SN - 0002-953X

VL - 145

SP - 748

EP - 750

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

IS - 6

ER -

A carbamazepine trial in chronic, treatment-refractory schizophrenia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this